bentoglucerasa
Pre-clinical- Indications
- Gaucher disease type I
Company intelligence / Profile preview
Bionaturis develops biotechnological solutions primarily for animal health—including vaccines, feed additives, probiotics—and has expanded its portfolio through acquisitions such as ZIP Solutions. Its proprietary platforms facilitate the production/purification of complex proteins. The company merged with ADL Biopharma to form a larger entity focused on both human and animal biotech markets. It operates globally as part of the Biat Group.
2 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bionaturis.